Adenovirus-mediated kallikrein gene transfer inhibits neointima formation via increased production of nitric oxide in rat artery

Immunopharmacology

Volumn 44, Issue 1-2, 1999, Pages 137-143

  Murakami, Hideyuki ^a   Miao, Robert Q ^a   Chao, Lee ^a   Chao, Julie ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Balloon angioplasty; Gene transfer; Kallikrein; Nitric oxide; Rat artery

Indexed keywords

CYCLIC GMP; KALLIKREIN; KININ; NITRIC OXIDE; TISSUE KALLIKREIN; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMMON CAROTID ARTERY; CONTROLLED STUDY; GENE TARGETING; GENE THERAPY; GENE TRANSFER; INTIMA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADENOVIRIDAE; ANGIOPLASTY, BALLOON; ANIMALS; AORTA; CAROTID ARTERIES; CYCLIC GMP; ENZYME INHIBITORS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; KALLIKREINS; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS; RATS, SPRAGUE-DAWLEY; TISSUE KALLIKREINS; TUNICA INTIMA;

EID: 0032760871     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(99)00120-4     Document Type: Article

References (22)

1. Becker T.C., Noel R.J., Coats W.S., Gomez-Foix A.M., Alam T., Gerard R.D., Newgard C.B. Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol. 43:1994;161-189.
2. Bhoola K.D., Figueroa C.D., Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol. Rev. 44:1992;1-80.
3. Chao J., Zhang J., Lin K.F., Chao L. Adenovirus-mediated kallikrein gene delivery attenuates hypertension, cardiac hypertension and renal injury in Dahl-salt sensitive rats. Hum. Gene Ther. 9:1998;21-31.
4. Chen L., Daum G., Forough R., Clowes M., Walter U., Clowes A.W. Overexpression of human endothelial nitric oxide synthase in rat vascular smooth muscle cells and in balloon-injured carotid artery. Circ. Res. 82:1998;862-870.
5. Clowes A.W., Reidy M.A., Clowes M.M. Mechanisms of stenosis after arterial injury. Lab. Invest. 49:1983;208-215.
6. Dixon B.S., Dennis M. Interaction between growth factors and kinins in arterial smooth muscle cells. Immunopharmacology. 33:1996;16-23.
7. Farhy R.D., Ho K.L., Carretero O.A., Scicli A.G. Kinins mediate the antiproliferative effect of ramipril in rat carotid artery. Biochem. Biophys. Res. Commun. 182:1992;283-288.
8. Farhy R.D., Carretero O.A., Ho K.L., Scicli A.G. Role of kinins and nitric oxide in the effects of ACE inhibition on neointima formation. Circ. Res. 72:1993;1202-1210.
9. Garg U.C., Hassid A. A nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 83:1989;1774-1777.
10. Huckle W.R., Earp H.S. Regulation of cell proliferation and growth by angiotensin II. Progress in Growth Factor Research. 5:1994;177-194.
11. Jin L., Zhang J., Chao L., Chao J. Gene therapy in hypertension: adenovirus-mediated kallikrein gene therapy in hypertensive rats. Hum. Gene Ther. 8:1997;1753-1761.
12. Kauffman R.F., Bean J.S., Zimmerman K.M., Brown R.F., Steinberg M.I. Losartan, a nonpeptide angiotensin II (ANGII) receptor antagonist, inhibits neointima formation following balloon injury to rat carotid arteries. Life Sci. 49:1991;PL223-PL228.
13. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
14. Misko T.P., Schilling R.J., Salvemini D., Moore W.M., Currie M.G. A fluorometric assay for the measurement of nitrite in biological samples. Analytical Biochemistry. 214:1993;11-16.
15. Murakami H., Yayama K., Chao L., Chao J. Human kallikrein gene delivery protects against gentamycin-induced nephrotoxicity in rats. Kidney Int. 53:1998;1305-1313.
16. Oza N.B., Schwartz J.H., Goud H.D., Levinsky N.G. Rat aortic smooth muscle cells in culture express kallikrein, kininogen, and bradykininase activity. J. Clin. Invest. 85:1990;597-600.
17. Pauletto P., Sartore S., Pessina A.C. Smooth-muscle-cell proliferation and differentiation in neointima formation and vascular restenosis. Clin. Sci. 87:1994;467-479.
18. Powell J.S., Clozel J.P., Müller R.K.M., Kuhn H., Hefti F., Hosang M., Baumgartner H.R. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science. 245:1989;186-188.
19. Sharma J.N., Uma K., Noor A.R., Rahman A.R. Blood pressure regulation by the kallikrein-kinin system. Gen. Pharmacol. 27:1996;55-63.
20. Wang J., Xiong W., Yang Z., Davis T., Dewey M.J., Chao J., Chao L. Human tissue kallikrein induces hypotension in transgenic mice. Hypertension. 23:1994;236-243.
21. Wolf W., Russell A.H., Dan S., Chao L., Chao J. Localization and expression of tissue kallikrein and kallistatin in human blood vessels. J. Histochem. Cytochem. 47:1999;221-228.
22. Yayama K., Wang C., Chao L., Chao J. Kallikrein gene delivery attenuates hypertension, cardiac hypertrophy and enhances renal function in Goldblatt hypertensive rats. Hypertension. 31:1998;1104-1110.